ProfileGDS4718 / 218875_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 56% 28% 43% 43% 43% 85% 84% 54% 33% 57% 54% 61% 72% 84% 86% 65% 54% 85% 78% 63% 51% 56% 59% 57% 64% 74% 47% 76% 57% 74% 71% 77% 16% 43% 62% 76% 84% 49% 48% 51% 52% 84% 60% 82% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8680356
GSM549102patient 115, normal, homogenized [OPG study]4.4783828
GSM549104patient 119, normal, homogenized [OPG study]5.1308843
GSM549108patient 138, normal, homogenized [OPG study]5.2119543
GSM549119patient 077, normal, homogenized [OPG study]5.1342243
GSM549133patient 032, cancer, homogenized [OPG study]8.6368585
GSM549139patient 042, cancer, homogenized [OPG study]8.3612184
GSM549099patient 107, normal, homogenized [OPG study]5.7379754
GSM549109patient 139, normal, homogenized [OPG study]4.7147433
GSM549110patient 046, normal, homogenized [OPG study]5.9487357
GSM549114patient 063, normal, homogenized [OPG study]5.6947754
GSM549122patient 082, normal, homogenized [OPG study]6.1995461
GSM549134patient 033, cancer, homogenized [OPG study]7.0797672
GSM549136patient 036, cancer, homogenized [OPG study]8.4327184
GSM549140patient 044, cancer, homogenized [OPG study]8.680586
GSM549111patient 047, normal, homogenized [OPG study]6.5146365
GSM549113patient 057, normal, homogenized [OPG study]5.6908154
GSM549132patient 031, cancer, homogenized [OPG study]8.4005185
GSM549137patient 038, cancer, homogenized [OPG study]7.7276878
GSM549142patient 047, cancer, homogenized [OPG study]6.390463
GSM549100patient 110, normal, homogenized [OPG study]5.5586951
GSM549107patient 135, normal, homogenized [OPG study]5.8743956
GSM549115patient 068, normal, homogenized [OPG study]6.0273559
GSM549116patient 072, normal, homogenized [OPG study]5.9577157
GSM549120patient 078, normal, homogenized [OPG study]6.4002264
GSM549131patient 030, cancer, homogenized [OPG study]7.3430274
GSM549118patient 074, normal, homogenized [OPG study]5.3491947
GSM549129patient 027, cancer, homogenized [OPG study]7.4833176
GSM549123patient 088, normal, homogenized [OPG study]5.9115757
GSM549124patient 006, cancer, homogenized [OPG study]7.1966874
GSM549126patient 015, cancer, homogenized [OPG study]6.9366371
GSM549128patient 025, cancer, homogenized [OPG study]7.634277
GSM549103patient 117, normal, homogenized [OPG study]4.0485316
GSM549117patient 073, normal, homogenized [OPG study]5.079743
GSM549138patient 041, cancer, homogenized [OPG study]6.3083862
GSM549141patient 045, cancer, homogenized [OPG study]7.5923976
GSM549130patient 028, cancer, homogenized [OPG study]8.303584
GSM549101patient 111, normal, homogenized [OPG study]5.46949
GSM549105patient 128, normal, homogenized [OPG study]5.4084748
GSM549106patient 134, normal, homogenized [OPG study]5.500451
GSM549112patient 048, normal, homogenized [OPG study]5.6322652
GSM549125patient 011, cancer, homogenized [OPG study]8.2815984
GSM549127patient 024, cancer, homogenized [OPG study]6.1545460
GSM549135patient 035, cancer, homogenized [OPG study]8.2131782